Population-based studies including systematic echocardiographic examinations are
required to assess the prevalence of valvular heart disease. In industrialized countries, the …

Valvular heart disease remains common in industrialized countries, because the decrease
in prevalence of rheumatic heart diseases has been accompanied by an increase in that of …

Background: The morbidity and mortality of patients with functional mitral regurgitation (MR)
remain high, but no pharmacological therapy has been proven effective. The hypothesis of …

Background In a trial comparing coronary-artery bypass grafting (CABG) alone with CABG
plus mitral-valve repair in patients with moderate ischemic mitral regurgitation, we found no …

Background Ischemic mitral regurgitation is associated with increased mortality and
morbidity. For surgical patients with moderate regurgitation, the benefits of adding mitral …

Once myocardium dies during a heart attack, it is replaced by scar tissue over the course of
several weeks. The size, location, composition, structure and mechanical properties of the …

The ACC and the AHA have long been involved in the joint development of practice
guidelines designed to assist healthcare providers in the management of selected …

Mitral regurgitation affects more than 2 million people in the USA. The main causes are
classified as degenerative (with valve prolapse) and ischaemic (ie, due to consequences of …

The ACC and the AHA have long been involved in the joint development of practice
guidelines designed to assist healthcare providers in the management of selected …

Importance The outcomes of patients with left ventricular (LV) dysfunction and secondary
mitral regurgitation (SMR) are still controversial. Objective To clarify the role of SMR in the …